Betalutin

· Nordic Nanovector

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Betalutin, covering 2023-12-22 to 2024-01-16. Get the full timeline:

Most recent: Clinical Trial Update: Study of Betalutin for Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma (LYMRIT-37-05) [Phase 1]